πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8298546

Isolation and purification of P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8298525

Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8288359

Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8283370

Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8282926

CCR5-specific antibodies with HIV neutralizing activity that recognize a linear dodecapept

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8278348

Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8278100

Lasonolide compounds as reagents for inducing premature chromosome condensation and method

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8278083

Inactivated influenza virus compositions

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8273797

Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehy

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268615

Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypep

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268323

Conformationally stabilized HIV envelope immunogens

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8263091

Method of treating and preventing infections in immunocompromised subjects with immunostim

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8258280

Plasmodium vivax hybrid circumsporozoite protein and vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8257915

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosc

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8252550

Targeting poly-Ξ³-glutamic acid to treat Staphylococcus epidermidis and related infections

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8252538

MicroRNA expression signature for predicting survival and metastases in hepatocellular car

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer Β· Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8247228

Method of inducing memory B cell development and terminal differentiation

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8247183

Compositions and methods for diagnosis and treatment of tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8236313

Prevention of tissue ischemia, related methods and compositions

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8232379

Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jul 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8232259

Multiple CpG oligodeoxynucleotide and their use to induce an immune response

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8227446

Oligodeoxynucleotide and its use to induce an immune response

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8227438

Suppressors of CpG oligonucleotides and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8222225

Method of treating pneumoconiosis with oligodeoxynucleotides

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted